University of Birmingham
Interrogating a role for tumour necrosis factor alpha in CD4\(^+\) T cell metabolism in health and inflammatory disease
Abstract
dc:description.abstractUpon activation, CD4+ T cells undergo substantial metabolic reprogramming to support clonal expansion and effector function, largely promoted by T cell receptor (TCR) and CD28 signalling. Whether T cell-derived inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α), amplify this process is not well understood but could be pertinent in chronic inflammatory diseases, such as rheumatoid arthritis (RA), where abundant TNF-α expression and dysregulated CD4+ T cell metabolic phenotypes are present. TNF-α has been previously identified to act as a co-stimulatory signal upon T cell activation, increasing proliferation and cytokine production. Yet, whether TNF-α controls CD4+ T cell metabolism has not been interrogated. Here, it was shown that blocking T cell-derived TNF-α supressed the activation of naïve CD4+ T cells and impaired their upregulation of glycolysis, amino acid uptake, and mitochondrial oxidation of glutamine. Conversely, addition of TNF-α was able to increase glycolysis in these cells. Interrogation of downstream signalling pathways identified that TNF-α drives these changes not through NFκB, which is most commonly reported to be downstream of TNF-α, but through the PI3K/Akt/mTOR pathway. T cell-derived TNF-α signalling was also shown to be involved in driving inflammatory T helper (Th)1 and Th17 cell differentiation in a partially Akt-dependent manner, whilst little effect on regulatory T cell (Treg) differentiation was observed. Finally, to interrogate a role for this TNF-α/PI3K/Akt metabolic axis in chronic inflammatory disease, peripheral blood CD4+ T cells from RA patients and healthy controls were analysed by flow cytometry. RA CD4+ T cells exhibited higher levels of membrane-bound TNF-α, mitochondrial mass, and Akt phosphorylation. These data implicate TNF-α signalling via PI3K/Akt in the dysregulated metabolic phenotype of RA CD4+ T cells.
Degree
thesis:*- Name dc:type.qualificationname
- d_ph
- Level dc:type.qualificationlevel
- d_ph
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bishop, Emma Louise
- ORCID person:identifier.orcid
Subjects
dc:subject × 2Rights
- Language dc:language.dcterms_iso639_2
- eng